Navigation Links
ARCA Discovery Changes Name to ARCA biopharma to Reflect Focus on Drug Commercialization
Date:3/28/2008

Company Appoints Randall St. Laurent as EVP of Commercial Operations

DENVER, March 28 /PRNewswire/ -- ARCA Discovery, Inc., a privately held company, today announced that it has changed its name to ARCA biopharma, effective immediately. In support of the commercial transformation, ARCA has appointed Randall St. Laurent as executive vice president of commercial operations.

"As we move toward the completion of our new drug application submission for bucindolol, we feel 'ARCA biopharma' better reflects our biological heritage in genetic targeting and focus on commercialization of pharmaceutical products for cardiovascular patients," said Richard B. Brewer, president and chief executive officer of ARCA. "At the same time, we continue to emphasize our basic research programs in molecular genetics, which are the key to our successful drug development programs."

Mr. St. Laurent brings over 20 years of cardiovascular sales and marketing experience to ARCA. Over the past six years, most recently as vice president of commercial development at Scios, a Johnson & Johnson company, where Mr. St. Laurent played a pivotal role in the successful launch and commercialization of Natrecor, a recombinant form of BNP for acute heart failure. During his tenure at Scios he created and built a sales organization from the bottom up.

"At this critical juncture, we welcome Randy as an important addition to our team as we transition to a commercial organization. Randy's cardiovascular sales and marketing experience will be critical in bringing our lead product, bucindolol, to market, possibly as the first personalized cardiovascular medicine ever commercialized," added Mr. Brewer.

The company plans to file a New Drug Application (NDA) with the U.S. Food and Drug Administration (FDA) within the next few months for its lead product candidate, bucindolol, for the treatment of chronic heart failure (HF) in patients with a specific genetic profile. ARCA plan
'/>"/>

SOURCE ARCA Discovery, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related medicine news :

1. GeneGo Rolls out MetaMiner Cystic Fibrosis - the First Disease-Specific Software Platform to Advance Drug Discovery
2. Baby Madness is Sweeping the Nation! Forty Sets of Twins and Triplets Hit the Court in Discovery Healths BABY MADNESS: MULTIPLES
3. Novel discovery by Einstein scientists could lead to much-needed kidney failure treatment
4. New protein discovery helps researchers understand autoimmune diseases
5. Specialists in drug discovery and development convene
6. Keystone Programs for Collaborative Discovery Launch at Fox Chase
7. Natural Products Discovery and Production
8. AMD discovery: New hope for treatment of vision loss
9. Merging discovery with therapy: Second generation memory care debuts
10. Moving beyond tamoxifen: Drug discovery and the future of selective hormone receptor modulators
11. Southern Research Institute Names Blaine Knight Vice President of Drug Discovery
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/5/2015)... Florida (PRWEB) March 05, 2015 ... organization which provides vascular, echocardiogram and NCV ... F.A.C.C. as the Chief Medical Officer. Dr. Artel will ... the development of the WimbledonMED program and the continued ... been passionate about working with Wimbledon Health Partners as ...
(Date:3/5/2015)... March 05, 2015 March 5, 2015 ... off next week (March 8-14, 2015), children’s hospitals around ... play in making hospital stays as safe as possible ... children’s hospitals—Children’s Hospitals’ Solutions for Patient Safety (SPS) and ... for families to follow when visiting the hospital with ...
(Date:3/5/2015)... March 05, 2015 The MTC 5-day ... to assist doctors, from a variety of dental disciplines, ... Shelly Akazany explains. "From the onset we wanted this ... doctors, and thanks to the excellence of the lecturers ... participants, it has more than satisfied our aims." ...
(Date:3/5/2015)... What makes a legend? In the case of renowned ... of exceptional courtroom performance, championing big causes and underdogs alike ... brilliant service, the Dallas Bar Association has named Schmidt a ... at a luncheon on Tuesday, April 7, 2015 at 12 ... nominees for this year are Bob Vial, Deborah Hankinson and ...
(Date:3/5/2015)... Lakeview Regional Medical Center is ... American Heart Association’s Heart Walk as the Signature Heart ... Executive Officer, is serving as Chairman of the event, ... at Fontainebleau State Park beginning at 9AM. In addition ... teams participating in this year’s event. Anyone is welcome ...
Breaking Medicine News(10 mins):Health News:Wimbledon Health Partners Appoints Chief Medical Officer to Attain Medicare Market Share 2Health News:Wimbledon Health Partners Appoints Chief Medical Officer to Attain Medicare Market Share 3Health News:Children’s Hospitals Offer Safety Tips for Patient Families During National Patient Safety Awareness Week 2Health News:Children’s Hospitals Offer Safety Tips for Patient Families During National Patient Safety Awareness Week 3Health News:Children’s Hospitals Offer Safety Tips for Patient Families During National Patient Safety Awareness Week 4Health News:MIS Global Training Center (MTC) Launches its Fundamental Implantology Course for Doctors - with a Difference 2Health News:C.L. Mike Schmidt Named "Legend In Trial Law" by Dallas Bar Association 2Health News:Get Your Heart Set on Walking a Better "Path" - Lakeview Regional Medical Center Sponsors Northshore Heart Walk 2Health News:Get Your Heart Set on Walking a Better "Path" - Lakeview Regional Medical Center Sponsors Northshore Heart Walk 3
... Million in Compensation and Benefits, MINNEAPOLIS, Dec. 6 ... William McGuire, today agreed to,terms with the UnitedHealth Special ... than $420 million in stock options and other,compensation to ... during,his tenure as CEO of the company, in addition ...
... against colorectal, prostate and oral tumors , , THURSDAY, ... from black raspberries, a fruit beverage and old-fashioned ... to treat or prevent different types of cancer, ... not been considered good treatments for chronic illness, ...
... Inc. (NYSE: WPI ), a leading ... reached a settlement with Novartis,Pharmaceuticals Corporation, Novartis ... and Proterra AG (collectively,"Novartis") on outstanding patent ... (rivastigmine tartrate) capsules., Under the terms ...
... (Nasdaq: NBIX ) announced today that the ... Veralliance Properties for its real estate,assets. Total consideration ... Concurrently with the closing of the transaction, Neurocrine,leased ... term, with renewal,options. Neurocrine also has certain options ...
... EXEL ) announced today that that it will hold ... of Hematology,48th Annual Meeting from 8:00 p.m. to 9:00 p.m. ... webcast and may be accessed in the Event Calendar,page under ... -- Michael Morrissey, PhD, President of Research & Development ...
... University of Pennsylvania School of Medicine and other ... care providers can better their chances of identifying ... the way they ask patients questions., In a ... Internal Medicine, researchers found a number of communication ...
Cached Medicine News:Health News:Dr. William McGuire Settles with the SEC and the UnitedHealth Group Special Litigation Committee on Stock Options Matter 2Health News:Dr. William McGuire Settles with the SEC and the UnitedHealth Group Special Litigation Committee on Stock Options Matter 3Health News:Green Tea, Fruit Extracts Touted as Potential Cancer Fighters 2Health News:Green Tea, Fruit Extracts Touted as Potential Cancer Fighters 3Health News:Watson and Novartis Settle Lawsuit Over Exelon(R) Patent Litigation 2Health News:Neurocrine Announces Closing of $109 Million Sale and Leaseback Agreement for its Real Estate Assets 2Health News:Reminder: Exelixis Announces December 10 Webcast of Its Analyst and Investor Briefing in Conjunction with The American Society Of Hematology 48th Annual Meeting 2Health News:Finding the right words: Provider-patient discussions can help domestic violence victims speak up 2
(Date:3/5/2015)... and VANCOUVER, British Columbia , ... FSE: 20B OTCQB: BMKDF) -- The ultimate goal in ... that is capable of detecting tumors before they become ... the development of such an assay has been the ... and industry. Although many breakthrough diagnostics have been invented ...
(Date:3/4/2015)... März 2015 Unfors RaySafe, ... Bereich diagnostische Röntgenstrahlung, stellte heute auf ... European Congress of Radiology (ECR) in ... einen neuen Strahlungsüberwachungssensor vor. ... Der RaySafe X2-Überwachungssensor stellt ...
(Date:3/4/2015)... 4, 2015  Vanda Pharmaceuticals Inc. (Vanda) (NASDAQ: ... of the Phase II proof of concept clinical ... as a monotherapy in the treatment of chronic ... highly significant and clinically meaningful improvement from baseline ... measured on a 100mm unit Visual Analog Scale ...
Breaking Medicine Technology:New Cancer Diagnostic Primed to Change the Industry 2New Cancer Diagnostic Primed to Change the Industry 3New Cancer Diagnostic Primed to Change the Industry 4Unfors RaySafe, ein Unternehmen von Fluke Biomedical, stellt auf European Congress of Radiology neuen Überwachungssensor vor 2Unfors RaySafe, ein Unternehmen von Fluke Biomedical, stellt auf European Congress of Radiology neuen Überwachungssensor vor 3Vanda Pharmaceuticals Announces Tradipitant Phase II Proof of Concept Study Results for Chronic Pruritus in Atopic Dermatitis 2Vanda Pharmaceuticals Announces Tradipitant Phase II Proof of Concept Study Results for Chronic Pruritus in Atopic Dermatitis 3Vanda Pharmaceuticals Announces Tradipitant Phase II Proof of Concept Study Results for Chronic Pruritus in Atopic Dermatitis 4Vanda Pharmaceuticals Announces Tradipitant Phase II Proof of Concept Study Results for Chronic Pruritus in Atopic Dermatitis 5Vanda Pharmaceuticals Announces Tradipitant Phase II Proof of Concept Study Results for Chronic Pruritus in Atopic Dermatitis 6Vanda Pharmaceuticals Announces Tradipitant Phase II Proof of Concept Study Results for Chronic Pruritus in Atopic Dermatitis 7
... its Footprint by Acquiring 33 Retail Pharmaceutical Stores -- LIUZHOU CITY, China, Sept. 27 /PRNewswire-Asia-FirstCall/ -- ... ... if (typeof(lpUnit)==,undefined,) var lpUnit=,PRN,; --> ... shortURL = ""; BitlyCB.alertResponse = function(data) { var s = ,; var first_result; // Results are ...
... Inc ., (Nasdaq: OMCL ) a leading ... today announced Deaconess Health System,s selection of ... SecureVault™ controlled substance security system to improve ... across the health system network. Deaconess chose to replace ...
Cached Medicine Technology:China BCT Further Expands its Footprint by Acquiring 33 Retail Pharmaceutical Stores 2China BCT Further Expands its Footprint by Acquiring 33 Retail Pharmaceutical Stores 3China BCT Further Expands its Footprint by Acquiring 33 Retail Pharmaceutical Stores 4China BCT Further Expands its Footprint by Acquiring 33 Retail Pharmaceutical Stores 5China BCT Further Expands its Footprint by Acquiring 33 Retail Pharmaceutical Stores 6China BCT Further Expands its Footprint by Acquiring 33 Retail Pharmaceutical Stores 7China BCT Further Expands its Footprint by Acquiring 33 Retail Pharmaceutical Stores 8Deaconess Health System Selects Omnicell's Medication Management System for Product Reliability and Improved Patient Care 2Deaconess Health System Selects Omnicell's Medication Management System for Product Reliability and Improved Patient Care 3
IDS Rapid SS/u, a microbial identification system....
Versatrek 240 is versatile as four tests can be performed on one platform such as blood culture, sterile body fluids, mycobacteria and mycobacteria susceptibility testing. This model comes equipped w...
ELP 40- 8 Way Head Strip Plate Washer....
The 96 PW is an intelligent full microplate washer with a 96 needle wash head washing all wells simultaneously. This instrument gives high throughput and outstanding washing efficiency....
Medicine Products: